REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 1 filers reported holding REPROS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $78,000 | +105.3% | 118,000 | 0.0% | 0.00% | – |
| Q3 2017 | $38,000 | -29.6% | 118,000 | 0.0% | 0.00% | – |
| Q2 2017 | $54,000 | -62.0% | 118,000 | 0.0% | 0.00% | – |
| Q1 2017 | $142,000 | -9.0% | 118,000 | 0.0% | 0.00% | – |
| Q4 2016 | $156,000 | -36.8% | 118,000 | 0.0% | 0.00% | – |
| Q3 2016 | $247,000 | +30.0% | 118,000 | 0.0% | 0.00% | – |
| Q2 2016 | $190,000 | +66.7% | 118,000 | 0.0% | 0.00% | – |
| Q1 2016 | $114,000 | -20.3% | 118,000 | 0.0% | 0.00% | – |
| Q4 2015 | $143,000 | -83.7% | 118,000 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $877,000 | +3.9% | 118,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $844,000 | +83.9% | 118,000 | +118.5% | 0.00% | 0.0% |
| Q1 2015 | $459,000 | 0.0% | 54,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $459,000 | -14.2% | 54,000 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $535,000 | -42.7% | 54,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $934,000 | +9.4% | 54,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $854,000 | -16.4% | 54,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,022,000 | -30.3% | 54,000 | -1.3% | 0.00% | -66.7% |
| Q3 2013 | $1,466,000 | +73.9% | 54,700 | +19.7% | 0.00% | +50.0% |
| Q2 2013 | $843,000 | – | 45,689 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $8,096,000 | 1.86% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,353,000 | 0.56% |
| RTW INVESTMENTS, LP | 229,364 | $1,640,000 | 0.48% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 182,500 | $1,305,000 | 0.41% |
| GENERAL AMERICAN INVESTORS CO INC | 601,553 | $4,301,000 | 0.35% |
| Baker Brothers Advisors | 1,955,944 | $13,985,000 | 0.12% |
| CQS Cayman LP | 240,000 | $1,716,000 | 0.10% |
| Gruss Capital Management LP | 304,000 | $2,174,000 | 0.08% |
| J. Goldman & Co LP | 101,881 | $728,000 | 0.04% |
| Squarepoint Ops LLC | 18,800 | $134,000 | 0.04% |